pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 15·1 min read
save

Mayo Clinic whistleblower alleges AI misuse, consent and privacy violations

Jul 15, 2026·read at STAT ↗RegulatoryNegative

The AI Prognosis newsletter from STAT reports that a whistleblower has come forward with serious concerns about the Mayo Clinic's use of artificial intelligence in patient care. The individual claims that the clinic's AI systems are being deployed in ways that may compromise patient consent and privacy.

According to the filing, the whistleblower alleges that the AI tools do not meet established standards for data protection and that patients may not be adequately informed about how their information is being used. The complaint suggests that these practices could expose patients to risks and undermine trust in the clinic's technology initiatives.

The newsletter also notes a related development involving Sutter Health, which has responded to a lawsuit concerning the Abridge scribe platform. Both stories highlight growing scrutiny of AI applications in health care and the importance of regulatory oversight.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: The whistleblower, The Lab, and the fine print”

read at STAT ↗
547 words · retrieved Jul 15
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Mayo Clinic2
drugs
DisPATCH

related stories

  • Oct 6BioSpace 40 Under 40 winners make their mark on biopharmaBioSpace
  • Sep 24The FDA’s Overton era, and dispatches from ShanghaiSTAT
  • Sep 22New federal autism committee head has financial ties to leucovorinSTAT
  • Sep 18Who supports policies for ‘health equity’? It depends on how you’re askingSTAT
  • Sep 15Mayo Clinic teams with Thermo Fisher to form biomedical data group PrecureFierce Biotech